Wednesday, September 09, 2026 Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trialThis secondary analysis evaluated the treatment adherence, adverse events, and survival in older (≥70 years) adults undergoing perioperative treatment for gastric cancer.Rühle A, Krause A, O'Connell RL, Simes J, Michael M, Smithers BM, Wong RKS, Haustermans K, Nicolay NH, Leong T, Lordick F. Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial (ONLINE). European Journal of Cancer 2026. https://www.sciencedirect.com/science/article/pii/S0959804926007860
